Literature DB >> 19557862

Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases.

Inés García-Gorostiaga, Pascual Sánchez-Juan, Ignacio Mateo, Eloy Rodríguez-Rodríguez, Coro Sánchez-Quintana, Soraya Curiel del Olmo, José Luis Vázquez-Higuera, José Berciano, Onofre Combarros, Jon Infante.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19557862     DOI： 10.1002/ana.21687

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  9 in total

1.  Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.

Authors:  Ignacio F Mata; Dora Yearout; Victoria Alvarez; Eliecer Coto; Lorena de Mena; Renee Ribacoba; Oswaldo Lorenzo-Betancor; Lluis Samaranch; Pau Pastor; Sebastian Cervantes; Jon Infante; Ines Garcia-Gorostiaga; Maria Sierra; Onofre Combarros; Katherine W Snapinn; Karen L Edwards; Cyrus P Zabetian
Journal:  Mov Disord       Date:  2011-03-21       Impact factor: 10.338

Review 2.  Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.

Authors:  Xuling Li; Simon James; Peng Lei
Journal:  J Mol Neurosci       Date:  2016-09-15       Impact factor: 3.444

3.  GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.

Authors:  Carol Dobson-Stone; Patsie Polly; Mayuresh S Korgaonkar; Leanne M Williams; Evian Gordon; Peter R Schofield; Karen Mather; Nicola J Armstrong; Wei Wen; Perminder S Sachdev; John B J Kwok
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

4.  GSK-3 in Neurodegenerative Diseases.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush; Paul A Adlard
Journal:  Int J Alzheimers Dis       Date:  2011-05-04

5.  Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease.

Authors:  L Lim; V Jackson-Lewis; L C Wong; G H Shui; A X H Goh; S Kesavapany; A M Jenner; M Fivaz; S Przedborski; M R Wenk
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

6.  Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.

Authors:  Ravi S Akundi; Zhenyu Huang; Joshua Eason; Jignesh D Pandya; Lianteng Zhi; Wayne A Cass; Patrick G Sullivan; Hansruedi Büeler
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

Review 7.  GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration.

Authors:  Tomasz Jaworski; Ewa Banach-Kasper; Katarzyna Gralec
Journal:  Neural Plast       Date:  2019-05-02       Impact factor: 3.599

Review 8.  Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward.

Authors:  Sara Melisa Arciniegas Ruiz; Hagit Eldar-Finkelman
Journal:  Front Mol Neurosci       Date:  2022-01-21       Impact factor: 5.639

9.  MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.

Authors:  Lan Yu; Jinsha Huang; Desheng Zhai; Ling Liu; Kexin Guo; Xi Long; Jing Xiong; Zhentao Zhang; Youpei Wang; Ying Zhao; Ping Wu; Dingan Wang; Zhicheng Lin; Jing Wu; Nian Xiong; Tao Wang
Journal:  BMC Neurosci       Date:  2014-04-29       Impact factor: 3.288
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.